MedTrace Logo

Cardiovascular Multimodality Imaging Study

NCT06610019 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-02-14

No results posted yet for this study

Summary

Determining the etiology of cardiomyopathy is of high clinical importance for optimal treatment strategy and prediction of prognosis. There is increased risk for cardiovascular disease and higher propensity for cardiovascular related mortality among Black and non-Hispanic White patients. Recently, advanced cardiac imaging has become a vital tool in diagnosis and risk stratification of cardiovascular disease. Very limited data is available on the prevalence and characteristics of different cardiovascular diseases in Hispanic and African American minority groups, therefore, studying different racial and ethnic minority groups in the Bronx population is an exceptionally valuable source to determine the prevalence of cardiomyopathies among minority groups along with study survival in this population. This study aims to determine the etiology of cardiovascular disease in a diverse patient population by utilizing various cardiovascular imaging modalities, with a focus on cardiac magnetic resonance (CMR) imaging and to develop risk stratification models by applying advanced cardiovascular imaging markers.

Conditions

  • Non-ischemic Cardiomyopathy
  • Cardiomyopathies
  • Hypertrophic Cardiomyopathy
  • Right Ventricular Arrhythmogenic Cardiomyopathy
  • Cardiac Amyloidosis
  • Anderson Fabry Disease
  • Sarcoidosis
  • Cancer Therapy-related Cardiac Dysfunction
  • Ventricular Arrythmia
  • Heart Failure

Sponsors & Collaborators

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Leandro Slipczuk, MD, PhD · Montefiore Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2031-12-31
Completion
2031-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06610019 on ClinicalTrials.gov